318 related articles for article (PubMed ID: 18079234)
1. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.
Garrido M; O'Brien A; González S; Clavero JM; Orellana E
Chest; 2007 Dec; 132(6):1997-9. PubMed ID: 18079234
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer.
Shogbon AO; Hap J; Dretler R; Dalvi AG
J Pharm Pract; 2013 Feb; 26(1):62-6. PubMed ID: 22842502
[TBL] [Abstract][Full Text] [Related]
3. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J
Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
[TBL] [Abstract][Full Text] [Related]
6. [A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Hoshikawa K; Aoki K; Noda H; Oyama K; Nitta H; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1965-7. PubMed ID: 19011353
[TBL] [Abstract][Full Text] [Related]
7. [Obliterative bronchiolitis with organising pneumonia following FOLFOX 4 chemotherapy].
Dahlqvist C; Fremault A; Carrasco J; Colinet B
Rev Mal Respir; 2010; 27(1):84-7. PubMed ID: 20146958
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.
Park SH; Sung JY; Han SH; Baek JH; Oh JH; Bang SM; Cho EK; Shin DB; Lee JH
Jpn J Clin Oncol; 2005 Sep; 35(9):531-5. PubMed ID: 16027146
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
Mitsuboshi S; Kozakai H; Yamada H; Nagai K; Furukawa T; Aizawa K
J Oncol Pharm Pract; 2018 Oct; 24(7):540-543. PubMed ID: 28696176
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery.
AlGizawy SM; Essa HH; Ahmed BM
Oncologist; 2015 Jul; 20(7):752-7. PubMed ID: 26040621
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
12. Administration of oxaliplatin to a pregnant woman with rectal cancer.
Gensheimer M; Jones CA; Graves CR; Merchant NB; Lockhart AC
Cancer Chemother Pharmacol; 2009 Jan; 63(2):371-3. PubMed ID: 18357450
[TBL] [Abstract][Full Text] [Related]
13. [Epiphora in a patient receiving FOLFOX therapy].
Yatsuda C; Niimi M; Ono Y; Uto N; Iwagami E; Tanaka E; Yamato M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1989-91. PubMed ID: 19011359
[TBL] [Abstract][Full Text] [Related]
14. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
[TBL] [Abstract][Full Text] [Related]
15. [Effective cetuximab monotherapy for a case of recurrence rectal cancer after multiple previous chemotherapy treatment (FOLFOX, FOLFIRI)].
Tomita M; Kuboi K; Kameyama N; Mitsuhashi H; Matsumoto N; Hasegawa Y; Sekimoto Y
Gan To Kagaku Ryoho; 2011 Jan; 38(1):121-4. PubMed ID: 21368472
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
17. Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
Uehara K; Ishiguro S; Hiramatsu K; Nishio H; Takeuchi E; Takahari D; Yoshioka Y; Takahashi Y; Ebata T; Yoshimura K; Muro K; Nagino M
Jpn J Clin Oncol; 2011 Oct; 41(10):1229-32. PubMed ID: 21840871
[TBL] [Abstract][Full Text] [Related]
18. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
20. [Modified FOLFOX6 treatment for obstructive jaundice caused by hepatic lymph-node metastasis from liver metastases of rectal cancer--a case report].
Ishiguro T; Kitaoka T; Sakimoto T; Miyazaki T; Yokoyama M; Ishibashi K; Matsuki M; Inoue N; Sano M; Ishida H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2138-40. PubMed ID: 19106549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
